Fidelity Investments’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed -$4K 5485
2022
Q3
$4K Buy
8
+6
+300% +$4.71K ﹤0.01% 4399
2022
Q2
$1K Sell
2
-3
-60% -$4.71K ﹤0.01% 4740
2022
Q1
$16K Buy
+5
New +$13.1K ﹤0.01% 4086
2021
Q3
Hold
0
4712
2021
Q2
Sell
-230
Closed -$3.62M 4581
2021
Q1
$3.88M Sell
230
-47
-17% -$917K ﹤0.01% 2323
2020
Q4
$4.69M Sell
277
-1,113
-80% -$20.9M ﹤0.01% 2196
2020
Q3
$26M Sell
1,390
-483
-26% -$11.1M ﹤0.01% 1455
2020
Q2
$49.2M Buy
1,873
+731
+64% +$20.7M 0.01% 1168
2020
Q1
$25.1M Buy
+1,142
New +$18.2M ﹤0.01% 1312
2018
Q4
Sell
-127
Closed -$3.13M 3861
2018
Q3
$3.13M Sell
127
-57
-31% -$1.74M ﹤0.01% 2275
2018
Q2
$6.3M Hold
184
﹤0.01% 2083
2018
Q1
$7.27M Sell
184
-56
-23% -$2.13M ﹤0.01% 2049
2017
Q4
$11.1M Hold
240
﹤0.01% 1920
2017
Q3
$13.7M Buy
+240
New +$13.2M ﹤0.01% 1831

Other funds holding KALA

Fidelity Investments's KALA Position: Q4 2022 in Review

Fidelity Investments sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 8 shares — an estimated $4K sold.

Fidelity Investments first reported a position in KALA in Q3 2017 and held it in 13 quarters. The position peaked at $49.2M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Fidelity Investments reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Fidelity Investments sold 8 KALA BIO shares in Q4 2022, an estimated $4K.
  • Fidelity Investments first reported a position in KALA BIO in Q3 2017 and held it in 13 quarters.
  • Fidelity Investments's KALA BIO position peaked at $49.2M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.